🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — September 08, 2026

The four filings in the S&P 500 Consumer Staples stream for September 8, 2026, reveal a sector in flux, with a stark contrast between routine corporate governance and a major structural event. The most critical development is Kraft Heinz's voluntary delisting from Nasdaq, a high-materiality (9/10) negative signal that raises immediate questions about the company's strategic direction, access to capital, and shareholder value. This event overshadows two low-materiality (3/10) Regulation FD filings from Philip Morris International, which provided no new financial data or period-over-period comparisons, and a similarly routine director nomination from Estée Lauder. The absence of any financial results, guidance changes, or insider trading activity across the filings limits the ability to identify broad sector trends, but the Kraft Heinz delisting acts as a powerful, isolated risk signal. The key takeaway is a sector bifurcation: while most companies are engaged in standard disclosure, one major player is executing a drastic, potentially value-destructive corporate action that demands immediate investor scrutiny.

1 high priority 3 medium 4 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 08, 2026

The latest batch of S&P 500 Industrials filings reveals a heightened M&A cycle in the Aerospace and Defense subsector, highlighted by GE Aerospace's $11.75 billion acquisition of Consolidated Precision Products and Parker-Hannifin's planned $2.55 billion purchase of CIRCOR International's Aerospace business, signaling significant capital deployment into supply chain consolidation and high-end manufacturing scale. Insider activity presents a stark dichotomy: large, bullish purchases by affiliated 10% owners in Republic Services ($59.8M total) and an insider director at Uber ($5.3M total) contrast with routine but notable insider sales at Waste Management, suggesting diverging management conviction across waste services names. Period-over-period trend comparisons are not provided in filings themselves but forward-looking deal timelines (closing in H2 2027 for GE-CPP) indicate long-duration value creation play. Capital allocation is heavily tilted toward debt-financed M&A (Parker-Hannifin's $2B term loan) rather than shareholder returns this period, while the absence of guidance changes in these filings leaves catalysts rooted in deal closing milestones.

5 high priority 1 medium 6 total filings
· daily

US Material Events SEC 8-K Filings — September 08, 2026

The September 8, 2026, filings reveal a market heavily bifurcated between aggressive capital deployment in strategic M&A and deep distress in small-cap companies. The most significant themes are a wave of CHIPS Act-funded quantum computing investments (Rigetti, D-Wave) and transformative bank mergers (WaFd/EverBank, Eagle Financial/John Marshall), signaling a 'bigger is better' strategy in both tech and regional banking. Conversely, a cluster of micro-cap companies (Synergy CHC, Vivos Therapeutics, Aterian) are facing existential threats from bankruptcy, massive dilution, and Nasdaq delisting, highlighting a severe capital access crisis for weaker balance sheets. Insider activity is notably absent from the filings, but the sheer volume of officer changes (over 15) suggests broad corporate restructuring. The data shows a clear divergence: well-capitalized firms are pursuing growth via M&A and government grants, while cash-strapped entities are resorting to desperate financing measures, creating a 'flight to quality' environment.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 08, 2026

Today's insider trading digest reveals a bifurcated market: significant insider buying at Uber Technologies and SCHMID Group signals strong management conviction, while a wave of selling at Nayax Ltd. and Global-E Online suggests caution in the tech sector. The most notable transaction is a $5.3M open-market purchase by Uber's SVP, Andrew Macdonald, a rare and powerful bullish signal. Conversely, a coordinated sell-off by four Nayax executives (CSO, CEO, CMO, CFO) on the same day raises a major red flag. The data also highlights a pattern of insider option exercises at Jianpu Technology and Kamada Ltd., which are neutral but increase share supply. A large disposal by a 10% owner at eXp World Holdings warrants close monitoring. Overall, the digest points to selective conviction in value and growth names, contrasted with potential weakness in small-cap tech and shipping.

41 high priority 9 medium 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — September 08, 2026

The 14 filings for the Dow Jones 30 stream are dominated by routine director equity awards at Microsoft (12 filings), which are non-events for investment decision-making but confirm a stable governance structure. The only actionable signal comes from a significant insider sale at NVIDIA, where Director Mark Stevens sold ~$55M in stock across multiple transactions, a bearish signal given the magnitude and timing. UnitedHealth Group's filing is a low-materiality conference participation notice with no financial updates. The lack of period-over-period comparisons, forward-looking guidance, capital allocation changes, or M&A activity across these filings limits the depth of quantitative trend analysis. The key takeaway is the stark contrast between Microsoft's passive director compensation and NVIDIA's active insider selling, which warrants monitoring for further insider activity in the semiconductor space.

1 high priority 13 medium 14 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 08, 2026

This digest captures severe corporate distress signals across four US-listed companies, with two filing for Chapter 11 bankruptcy (Synergy CHC Corp. and Sangamo Therapeutics) and two receiving Nasdaq delisting warnings (Aterian, Inc. and Estrella Immunopharma). The filings reveal a common theme of liquidity crises and market value deterioration, with Synergy CHC entering bankruptcy with a complete board resignation and Sangamo posting a monthly loss of $11.2M despite $16.9M cash on hand. Both Aterian and Estrella face 180-day compliance windows to regain Nasdaq listing standards, but Estrella's failure to meet alternative equity or income thresholds makes its path particularly precarious. From a period-over-period perspective, Sangamo's cash burn of $11.2M in a single month (including $4.2M in reorganization costs) against $16.9M total cash implies a runway of less than 2 months, while Synergy's board exodus signals zero confidence in a going-concern turnaround. The aggregate market implication is a heightened risk of equity value destruction, with potential for distressed asset plays in the biotech and consumer health sectors.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — September 08, 2026

This digest covers 40 filings from September 8, 2026, with a heavy concentration on insolvency, M&A, and delisting events. A dominant theme is the surge in SPAC activity, with three separate business combination announcements (Navitas/Claros, Meshflow/HGP, NMP/Gibson Technical) and one termination (Cayson/Mango), signaling a potential revival in the SPAC market. The filings also reveal a cluster of bankruptcy and insolvency proceedings, including Synergy CHC's Chapter 11 filing and Sangamo Therapeutics' ongoing Chapter 11, alongside several Indian companies navigating the insolvency resolution process. A significant cybersecurity incident at Boston Scientific is expected to materially impact its Q3 and full-year 2026 results, while two companies (Aterian, Estrella Immunopharma) face Nasdaq delisting risks. A notable trend is the voluntary delisting of Cosan S.A. and Kraft Heinz from US exchanges, raising questions about the attractiveness of US listings for certain foreign and domestic issuers. The data also shows a clear pattern of asset sales and corporate simplification, as seen with Medalist Diversified REIT and International Stem Cell, both of which are reshaping their business profiles. Overall, the filings point to a market environment with high event risk, significant corporate restructuring, and a potential inflection point for SPAC activity.

40 high priority 40 total filings
· daily

US SEC Filings Daily Market Digest — September 08, 2026

Today's digest reveals a market bifurcated between aggressive capital structure maneuvers and significant corporate distress. The most dominant theme is the transformative $3.9 billion reverse merger between WaFd and EverBank, which will create a major regional banking player and is projected to deliver 29% EPS accretion for WaFd shareholders. However, this positive signal is counterbalanced by a wave of distress signals: Synergy CHC Corp filed for Chapter 11 bankruptcy, Cosan S.A. is voluntarily delisting from the NYSE, and Vivos Therapeutics is executing a highly dilutive debt-for-equity swap that will increase its share count by 52%. On the capital allocation front, we see a clear divergence—companies like Bilibili and Gilat Satellite are raising debt capital for growth, while Equinor continues its disciplined buyback program. Insider activity is sparse but notable, with UMC's CFO executing a large, neutral-position trade. The biotech sector shows a positive regulatory catalyst with Belite Bio's NDA submission in Japan, while the energy sector sees Pampa Energy gaining a favorable regulatory regime in Argentina. Overall, the day is characterized by high-conviction M&A, acute financial distress in small-caps, and strategic capital raises, demanding a selective, risk-aware approach.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — September 08, 2026

The sole filing for the S&P 500 Consumer Discretionary stream on this date is an insider transaction filing for DoorDash, Inc. The filing reveals that CEO Tony Xu executed a net-neutral transaction, disposing of and acquiring the same number of Class B Common Stock (31,428 shares). While the transaction itself is non-dilutive and sentiment-neutral, the context of a CEO engaging in a matched sale and acquisition of the same share count warrants attention. It could indicate tax-related planning or a pre-arranged trading plan, but it does not signal a change in management's conviction. With no other filings in the stream, there are no broader sector trends or comparative performance data to synthesize. The key takeaway is a lack of material directional signal from the C-suite at DoorDash, leaving the stock's outlook to be driven by upcoming operational results and broader market factors.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 08, 2026

The S&P 500 Healthcare sector is flashing a starkly mixed picture: a severe, material cybersecurity incident at Boston Scientific is set to disrupt near-term financials and guidance, while the rest of the filings point to routine corporate activity. The most critical development is Boston Scientific's disclosure of a network outage that will materially impact Q3 and full-year 2026 results, forcing a likely guidance miss and creating significant downside risk for the stock. In contrast, insider activity at Cigna and Moderna is low-materiality and largely neutral, with a CFO tax-withholding sale at Moderna being the only notable transaction. UnitedHealth's upcoming participation at a healthcare conference provides a near-term catalyst for sector sentiment but no new financial data. The overarching theme is one of operational risk (cyber) overwhelming otherwise quiet, routine corporate governance filings. There are no positive period-over-period trends or bullish capital allocation signals in this batch, reinforcing a cautious near-term stance on the sector.

4 high priority 1 medium 5 total filings
· daily

US Earnings Financial Results SEC Filings — September 08, 2026

The 19 filings for the period ending July 31, 2026, reveal a bifurcated market: high-growth tech and industrial companies (Samsara, Dell, Casey's) are delivering strong revenue and profit growth, while many smaller biotech and pre-revenue firms (enGene, MMEX, Braveheart) continue to burn cash with widening losses. A notable theme is the prevalence of 'mixed' sentiment (12 of 19 filings), often driven by non-recurring gains masking underlying operational weakness (e.g., Apnimed, G-III Apparel). Capital allocation is aggressive, with significant M&A (Mission Produce, ABM Industries) and share buybacks (Dell, UiPath, ABM) reshaping balance sheets. Insider trading activity is sparse, but the absence of insider buying in several cash-burning companies is a concern. The most critical development is Dell's 57.7% revenue surge, signaling robust AI-driven demand, contrasted with the gold ETF's 16% NAV decline, reflecting a macro shift away from safe havens. Overall, the data suggests a 'risk-on' environment favoring growth and operational leverage, while punishing companies without clear paths to profitability.

19 high priority 19 total filings
· daily

US Executive Compensation Proxy SEC Filings — September 08, 2026

The 7 filings in this executive compensation digest reveal a landscape dominated by corporate control events and governance restructuring, with limited direct executive pay data. The most critical development is Lantheus Holdings' pending acquisition, which will trigger significant change-of-control payments and delisting, representing a high-materiality event for shareholders. A pattern of shareholder dilution and listing compliance struggles is evident across iPower Inc. and Cayson Acquisition Corp, both seeking shareholder approval for actions that could severely impact equity value. Seagate Technology's proxy provides the most substantive executive compensation data, including a CEO pay ratio and pay-versus-performance disclosure, offering a benchmark for the sector. The remaining filings (Hussman Investment Trust, Richtech Robotics, Baillie Gifford ETF Trust) are lower materiality, focusing on routine governance matters like board elections and fund reclassification. Overall, the period-over-period comparisons are sparse, but the forward-looking data points to a catalyst-rich calendar with several shareholder meetings in late September through November 2026.

7 high priority 7 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 08, 2026

The September 8, 2026, IPO pipeline is dominated by a wave of capital-intensive filings from pre-revenue or early-stage companies, signaling a potential shift in market appetite toward high-risk, high-reward opportunities in deep tech and specialty pharma. The most critical development is Navitas Semiconductor's S-4 for its $232.8 million acquisition of Claros, Inc., a transformative deal that will reshape its capital structure and growth trajectory. A clear period-over-period trend is the heavy reliance on dilutive financing structures, with Ocean Power Technologies, Acurx Pharmaceuticals, and CDT Equity all utilizing best-efforts offerings, at-the-market facilities, or convertible notes, indicating persistent cash burn and a challenging fundraising environment for these issuers. The pipeline lacks broad sector cohesion but clusters around companies with significant operational risks, restated financials, and a history of losses, suggesting a 'show-me' story for investors. The most actionable insight is the divergence in capital allocation: Navitas is deploying M&A for growth, while others are purely raising survival capital, creating a clear quality spectrum within the cohort.

5 high priority 5 total filings
· daily

US SEC Trading Suspension Halt Orders — September 08, 2026

Both filings in this digest are from micro-cap companies facing imminent Nasdaq delisting risks, highlighting a concentrated wave of non-compliance among small-cap biotech and consumer goods firms. Aterian, Inc. received a bid price deficiency notice, compounded by the abrupt termination of its CFO, signaling severe internal turmoil and a high probability of failure to regain compliance. Estrella Immunopharma faces a more acute threat, failing not only the Market Value of Listed Securities (MVLS) test but also alternative equity and net income standards, leaving it with no viable path to compliance. The aggregate picture is one of heightened delisting risk in the micro-cap space, with both companies lacking the financial resources or operational catalysts to reverse their stock price declines. The lack of insider buying or positive forward guidance in either filing reinforces a bearish outlook for their near-term equity value.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — September 08, 2026

This digest of 50 SEC filings reveals a wave of executive leadership transitions across US equities, with a notable concentration of CFO changes and strategic appointments aimed at driving growth and operational efficiency. A key theme is the appointment of seasoned executives with strong track records in M&A, turnaround, and scaling businesses, such as at Pyxis Oncology, Kura Oncology, and Concentra Group. The data shows a mix of planned successions, like at Adobe and Markel Group, and abrupt departures, such as at TPG Inc. and Better Home & Finance, creating a spectrum of risk and opportunity. Insider activity is limited, but the compensation structures and background of new appointees provide strong signals about company strategy. The most critical developments include the high-profile CEO transition at Adobe, the strategic pivot at Health Catalyst with a new CEO who has a proven exit track record, and the leadership vacuum at TPG Inc. following an unexplained resignation. Portfolio-level patterns indicate a sector-agnostic trend towards appointing leaders with digital transformation, AI, and data analytics expertise, particularly in healthcare and financial services. The overall sentiment is cautiously positive, with many changes signaling a focus on value creation, though several departures without clear succession plans warrant close monitoring.

50 high priority 50 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — September 08, 2026

The two filings in this stream highlight a deeply distressed corporate landscape in the US, with both companies undergoing Chapter 11 bankruptcy proceedings. Synergy CHC Corp. filed for Chapter 11 on September 4, 2026, triggering a complete board overhaul and appointment of a Chief Restructuring Officer, signaling a likely liquidation or major reorganization. Sangamo Therapeutics, in its first monthly operating report post-petition, reveals a cash burn of $11.2 million in July 2026, with total liabilities of $97.1 million against $16.9 million cash, indicating a precarious liquidity position. Both companies exhibit negative sentiment and high materiality, with no positive forward-looking indicators. The lack of any period-over-period revenue or margin data in these filings suggests a focus on survival rather than operational performance. The sector theme is one of acute financial distress, with governance instability and rapid cash depletion as key risk factors.

2 high priority 2 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 08, 2026

The September 8, 2026 board room changes digest reveals a wave of leadership transitions across US-listed companies, with a notable concentration in the healthcare and technology sectors. CFO changes dominate the officer-level moves, with 10+ companies appointing or transitioning CFOs, often with rich compensation packages signaling strategic importance (e.g., Genpact's $3M signing bonus, Kura Oncology's performance-based RSUs). Several transitions are tied to broader strategic reviews or growth initiatives, such as Xponential Fitness's ongoing strategic alternatives review and Clearway Energy's AI-driven transformation office. While most changes are routine, a few carry heightened significance: Adobe's CEO transition (materiality 8/10), Health Catalyst's new CEO appointment (8/10), and StableCoinX's new CEO (7/10) signal potential strategic pivots. The overall sentiment is predominantly neutral (36/50), with a handful of positive (7) and negative (2) filings, suggesting no systemic distress but a period of active board and executive refreshment. No major period-over-period financial trends were disclosed in these filings, as most are event-driven 8-Ks without financial data.

50 high priority 50 total filings
· daily

USA Insider Trading Pulse — September 08, 2026

This digest of 50 insider trading filings from September 8, 2026, reveals a market characterized by cautious insider selling among mid-cap growth companies, particularly in the Israeli tech sector (Nayax, Global-E Online), contrasted with strong insider buying at select value and turnaround plays (Uber, OppFi, Comscore, SCHMID Group). The most significant capital market signal is the aggressive activity by Saba Capital Management, which is actively rotating out of BlackRock ESG Capital Allocation Term Trust ($3.2M sale) while accumulating positions in closed-end funds like Ellsworth Growth & Income Fund and Gabelli Healthcare & WellnessRx Trust, suggesting a targeted activist or arbitrage strategy. Insider award filings dominated the day, with 28 of 50 filings being non-cash compensation events (RSUs, stock options, dividend equivalents), which are neutral signals. However, the concentrated insider buying by CEOs at OppFi and Comscore, both trading at low absolute prices, indicates management conviction in undervalued assets. The data shows no significant period-over-period revenue or margin trends across the portfolio, as the filings are transaction-focused, but the insider activity patterns point to a bifurcated market where insiders are buying deeply discounted names and selling into strength in growth tech.

46 high priority 4 medium 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 08, 2026

The US M&A landscape is bifurcated between high-conviction, strategic acquisitions in industrial and defense tech and the ongoing, high-risk search for targets by cash-rich SPACs. A clear theme emerges of capital flowing into energy infrastructure (nuclear, power solutions) and autonomous systems, with acquisitions like Meshflow/HGP ($921M EV) and AEVEX/BlackSea signaling a premium on specialized technology. Conversely, the SPAC sector shows stress, with Cayson Acquisition's deal termination highlighting execution risk, while Andretti and B&R Technology remain in limbo. Period-over-period data reveals strong operational performance at acquired targets, such as Cat Pumps' 35%+ EBITDA margins and GTS's 36% YoY revenue growth, justifying premium valuations. However, the data also flags significant risk at International Stem Cell, where post-divestiture revenues collapsed to just $296K, and at Medalist Diversified REIT, which is effectively liquidating its asset base. The most critical development is the $800M+ nuclear tech deal, which positions the combined entity for massive government and AI-driven data center demand, while the Solaris acquisition of Omega Foundation Services signals a strategic pivot into the high-growth data center EPC market.

10 high priority 10 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 08, 2026

The overnight filing cycle reveals a market bifurcated between aggressive corporate restructuring and cautious capital management. The most significant development is the $3.9 billion reverse merger between WaFd and EverBank, creating a regional banking powerhouse with projected 29% EPS accretion for WaFd shareholders, though the fixed exchange ratio (59.2% to EverBank) signals a control premium. Concurrently, a wave of dilutive capital raises is sweeping through micro-cap and pre-revenue companies: Ocean Power Technologies (OPTT) is conducting a best-efforts offering with no minimum, Vivos Therapeutics is executing a 52% dilutive debt-to-equity swap, and Indaptus Therapeutics has opened a $100 million ATM facility. On the positive side, Circle Internet Group's acquisition of Tazapay for its stablecoin infrastructure and Belite Bio's NDA submission in Japan under the Sakigake designation represent high-conviction growth plays. The period-over-period data from Holtec Nuclear shows a 5.8% revenue decline but a swing to profitability, while AMC Networks' $120 million settlement forced a 32% cut to its free cash flow guidance, highlighting the financial drag from legacy litigation. Insider activity is sparse but notable: United Microelectronics Corp's CFO executed a large, simultaneous acquisition and disposition of 1 million shares, a neutral signal that warrants monitoring for future intent. The overall theme is one of portfolio cleansing—companies are aggressively addressing balance sheet issues, settling legal overhangs, and positioning for strategic shifts, creating both deep value traps and asymmetric upside opportunities for discerning investors.

15 high priority 35 medium 50 total filings